盈转亏 睿智医药(300149.SZ)预计2021年归母净亏3.95亿元至5.85亿元

智通财经APP讯，睿智医药(300149.SZ)披露2021年度业绩预告，公司预计归属于上市公司股东的净亏损3.95亿元至5.85亿元，由盈转亏;扣除非经常性损益后的净亏损4.05亿元至5.95亿元。

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.